HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Analysis of focused ultrasound-induced blood-brain barrier permeability in a mouse model of Alzheimer's disease using two-photon microscopy.

Abstract
Transcranial focused ultrasound (FUS) can cause temporary, localized increases in blood-brain barrier (BBB) permeability for effective drug delivery to the brain. In pre-clinical models of Alzheimer's disease, FUS has successfully been used to deliver therapeutic agents and endogenous therapeutic molecules to the brain leading to plaque reduction and improved behavior. However, prior to moving to clinic, questions regarding how the compromised vasculature in Alzheimer's disease responds to FUS need to be addressed. Here, we used two-photon microscopy to study changes in FUS-mediated BBB permeability in transgenic (TgCRND8) mice and their non-transgenic littermates. A custom-built ultrasound transducer was attached to the skull, covering a cranial window. Methoxy-X04 was used to visualize amyloid deposits in vivo. Fluorescent intravascular dyes were used to identify leakage from the vasculature after the application of FUS. Dye leakage occurred in both transgenic and non-transgenic mice at similar acoustic pressures but exhibited different leakage kinetics. Calculation of the permeability constant demonstrated that the vasculature in the transgenic mice was much less permeable after FUS than the non-transgenic littermates. Further analysis demonstrated that the change in vessel diameter following FUS was lessened in amyloid coated vessels. These data suggest that changes in vessel diameter may be directly related to permeability and the presence of amyloid plaque may reduce the permeability of a vessel after FUS. This study indicates that the FUS parameters used for the delivery of therapeutic agents to the brain may need to be adjusted for application in Alzheimer's disease.
AuthorsAlison Burgess, Tam Nhan, Clare Moffatt, A L Klibanov, Kullervo Hynynen
JournalJournal of controlled release : official journal of the Controlled Release Society (J Control Release) Vol. 192 Pg. 243-8 (Oct 28 2014) ISSN: 1873-4995 [Electronic] Netherlands
PMID25107692 (Publication Type: Journal Article)
CopyrightCopyright © 2014 Elsevier B.V. All rights reserved.
Chemical References
  • 1,4-bis(4'-hydroxystyryl)-2-methoxybenzene
  • Alkenes
  • Benzene Derivatives
  • Stilbenes
Topics
  • Alkenes
  • Alzheimer Disease (drug therapy, pathology)
  • Animals
  • Benzene Derivatives
  • Blood-Brain Barrier (metabolism, pathology)
  • Brain (blood supply, metabolism, pathology)
  • Cerebral Amyloid Angiopathy (metabolism, pathology)
  • Drug Delivery Systems (instrumentation)
  • Female
  • Male
  • Mice
  • Mice, Transgenic
  • Microscopy, Fluorescence, Multiphoton
  • Permeability
  • Plaque, Amyloid (metabolism, pathology)
  • Stilbenes
  • Ultrasonics (instrumentation)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: